The phrase "a prevalence of memory" is correct and usable in written English.
It can be used to describe a situation or context where memory is common or widespread, often in discussions about psychology, cognition, or data retention.
Example: "In this study, we observed a prevalence of memory among participants, indicating strong recall abilities."
Alternatives: "a dominance of memory" or "a commonality of memory".
For example, a study of Danish workers found that those whose occupations involved exposure to a mixture of organic solvents had a greater prevalence of memory loss and decreased ability to concentrate relative to a reference group (Hein et al. 1990).
The proportion of circulating immune effectors was similar in HER2+ patients and healthy donors, whereas higher percentages of natural killer and Treg cells and a lower CD4+/CD8+ T cell ratio (with a prevalence of naïve and central memory CD8+ T cells) were observed in HER2- cases.
Furthermore, these results are based on a very large population representative of the general population in West Virginia and Ohio 25; thus, the estimates are solid; and the 21% prevalence of memory impairment is compatible and consistent with the figures on the prevalence of dementia reported for North America.
An Egyptian study 14 showed a prevalence of neurological symptoms, such as headache, memory changes, dizziness, tremors, depressive symptoms and sleep disturbances among participants directly exposed to GSM signals from BSs.
In the MAASBED study, a prevalence of 80.9% at baseline increased to a cumulative prevalence of 88.9% after 2 years, and the cumulative incidence after 6 12 months was 74% in ambulatory patients of memory clinics or psychiatric services [ 15].
Studies by Shadic and co-workers from 1994 and 1999 found that persons with a history of LB had more musculoskeletal impairment and a higher prevalence of verbal memory impairment when compared with those without a history of LB [ 8, 9].
Earlier studies have reported a high prevalence of subjective memory complaints in 60 70 year olds [ 5] and a low risk of developing AD before age 75 [ 28].
Med. 24, 563 571 (2018).This paper correlates the clinical outcome of CAR T cell therapy with the prevalence of a memory precursor phenotype at the time of leukapheresis.
